Skilled Nursing Facility Care and Outcomes After Hospitalizations Involving Opioid Use Disorder
涉及阿片类药物使用障碍的住院后熟练护理机构的护理和结果
基本信息
- 批准号:10609800
- 负责人:
- 金额:$ 23.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdministratorAdmission activityAdultAreaCaringCertificationChronicCommunitiesComplexComputerized Medical RecordContinuity of Patient CareDataData SetDiagnosisDisabled PersonsDiscriminationEffectivenessElderlyEmergency department visitEnrollmentFaceFacility AccessesFee-for-Service PlansGoalsHealthHealth care facilityHealthcareHigh PrevalenceHomeHome Care ServicesHospitalizationHospitalsHuman ResourcesImprove AccessIndividualInfectionInpatientsInstitutionInterventionInterviewKnowledgeLawsLinkLocationLong-Term CareMedicalMedicareNeighborhoodsNurse AdministratorNursing HomesOpioidOutcomePainPatientsPersonsPharmacy facilityPoliciesPopulationProviderQuality of CareRecoveryRecovery SupportReportingResearchShapesSkilled Nursing FacilitiesStatutes and LawsStructureSuboxoneTelephone InterviewsTestingUnited States Centers for Medicare and Medicaid Servicesacute careaddictionage groupagedaging populationbeneficiarycare systemsdesigneffective interventionevidence baseflexibilityimprovedmedication for opioid use disordermortalitymultiple chronic conditionsopioid policyopioid treatment programopioid use disorderparticipant interviewpreventrecruitsubstance usewillingnessyoung adult
项目摘要
PROJECT SUMMARY
Opioid use disorder (OUD) is increasing in older adults (≥65 years) and among younger people with disabilities
who are enrolled in Medicare. Increased opioid-related hospitalizations and emergency department visits have
also been reported in this population. Comprehensive post-acute care (PAC) for people with OUD (PWOUD)
should address the care needs for both OUD treatment and other medical issues. As existing initiatives to prevent
and treat OUD primarily target community-based residents, much is still unknown about when and how PWOUD
interact with institutional settings for post-acute and long-term care such as skilled nursing facilities (SNFs).
There are also knowledge gaps about whether OUD represents a barrier to admission to higher quality SNFs,
the outcomes of PWOUD who enter SNFs, and about the capacity to deliver OUD treatment in these settings.
Yet, SNFs which are a dominant setting for institutional post-acute care SNFs are receiving more referrals for
PWOUD. The long-term goal of this research is eventual partnership with SNFs to improve the willingness and
capacity to provide medications for OUD (MOUD) for PWOUD in post-acute and long-term care settings. The
objective of this application, the first step toward this long-term goal, is to examine the quality of SNFs that admit
PWOUD, survival and health care trajectories after OUD-related hospitalization, and elicit provider perspectives
on strategies to improve access to MOUD in SNFs. The two-pronged study rationale is to address knowledge
gaps on SNF use and outcomes for PWOUD, and encourage better integration of addiction treatment with
gerontologic and post-acute care services. We will analyze 2015-2019 inpatient hospital claims for 100% fee-
for-service Medicare beneficiaries linked to or combined with other data (e.g., enrollment, Nursing Home
Compare, Minimum Data Set, Part D, Omnicare PAC pharmacy data and SNF electronic medical records). Our
Specific Aims are to: 1) Assess receipt of post-acute care by Medicare beneficiaries with OUD, including the
attributes of SNFs they enter, health care use and survival trajectories, and availability of providers for OUD
treatment in neighborhoods where SNFs are located. 2) Identify and describe barriers and facilitators for the
placement of PWOUD in nursing homes, and best practices for providing access to OUD treatment by eliciting
the views of nursing home personnel. In Aim 2, we will conduct semi-structured telephone interviews with nursing
home administrators, admissions coordinators, and direct care staff to obtain rich contextual information about
the mechanisms that shape post-acute SNF use and outcomes for PWOUD. The interviews will also provide
preliminary data to inform the design and potential feasibility of interventions to improve OUD treatment in SNFs.
Both aims will also examine whether SNF use and outcomes differ between younger and older adults with OUD.
Developing this evidence will enhance efforts to design and tailor effective interventions to treat OUD and
promote recovery in an aging population and across diverse care settings.
项目摘要
阿片类药物使用障碍(OUD)在老年人(≥65岁)和年轻残疾人中增加
参加医疗保险的人阿片类药物相关住院和急诊就诊的增加
在这一人群中也有报道。OUD患者的综合急性期后护理(PAC)(PWOUD)
应满足OUD治疗和其他医疗问题的护理需求。现有的预防措施
治疗OUD主要针对社区居民,但关于PWOUD何时以及如何治疗,
与急性期后和长期护理的机构环境互动,如熟练护理设施(SNF)。
关于OUD是否是进入更高质量SNF的障碍,
进入SNF的PWOUD的结果,以及在这些环境中提供OUD治疗的能力。
然而,SNF是机构急性后护理SNF的主要环境,
PWOUD。这项研究的长期目标是最终与SNF合作,以提高他们的意愿,
在急性期后和长期护理环境中为PWOUD提供OUD(MOUD)药物的能力。的
本申请的目的,朝着这个长期目标的第一步,是检查SNF的质量,
PWOUD,OUD相关住院后的生存和医疗保健轨迹,并引出提供者的观点
关于改善SNF中MOUD访问的战略。双管齐下的研究基本原理是解决知识
SNF使用和PWOUD结果的差距,并鼓励更好地将成瘾治疗与
老年病和急症后护理服务。我们将分析2015-2019年100%费用的住院医院索赔-
与其他数据链接或组合的服务Medicare受益人(例如,入组,疗养院
比较,最小数据集,D部分,Omnicare PAC药房数据和SNF电子病历)。我们
具体目标是:1)评估OUD的Medicare受益人接受的急性期后护理,包括
他们进入的SNF的属性,医疗保健使用和生存轨迹,以及OUD提供者的可用性
在SNF所在的社区进行治疗。2)确定并描述实现以下目标的障碍和促进因素:
将PWOUD安置在疗养院,以及通过引发
养老院工作人员的意见。在目标2中,我们将对护理人员进行半结构式电话访谈
家庭管理员、入院协调员和直接护理人员,以获取有关以下内容的丰富上下文信息:
形成急性后SNF使用和PWOUD结局的机制。采访还将提供
提供初步数据,为改善SNF中OUD治疗的干预措施的设计和潜在可行性提供信息。
这两个目标还将研究SNF的使用和结果是否在OUD的年轻人和老年人之间存在差异。
开发这些证据将加强设计和定制有效干预措施以治疗OUD的努力,
促进老龄化人口和各种护理环境的康复。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patience Moyo Dow其他文献
Patience Moyo Dow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patience Moyo Dow', 18)}}的其他基金
Impact of Medicaid Prescription Cap Policies on Treatment Outcomes for Opioid Use Disorder: A National Mixed Methods Study
医疗补助处方上限政策对阿片类药物使用障碍治疗结果的影响:一项国家混合方法研究
- 批准号:
10637024 - 财政年份:2023
- 资助金额:
$ 23.74万 - 项目类别:
Skilled Nursing Facility Care and Outcomes After Hospitalizations Involving Opioid Use Disorder
涉及阿片类药物使用障碍的住院后熟练护理机构的护理和结果
- 批准号:
10371281 - 财政年份:2022
- 资助金额:
$ 23.74万 - 项目类别:
Chronic Pain Management and Outcomes in Adults With and Without Opioid Use Disorder
有和没有阿片类药物使用障碍的成年人的慢性疼痛管理和结果
- 批准号:
10302666 - 财政年份:2021
- 资助金额:
$ 23.74万 - 项目类别:
Chronic Pain Management and Outcomes in Adults With and Without Opioid Use Disorder
有和没有阿片类药物使用障碍的成年人的慢性疼痛管理和结果
- 批准号:
10434917 - 财政年份:2021
- 资助金额:
$ 23.74万 - 项目类别:
Trends and racial/ethnic differences in opioid prescribing safety and use of nonpharmacologic treatments for chronic pain in adults with co-occurring opioid use disorder
患有并发阿片类药物使用障碍的成人慢性疼痛的阿片类药物处方安全性和非药物治疗使用的趋势和种族/民族差异
- 批准号:
10666622 - 财政年份:2019
- 资助金额:
$ 23.74万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.74万 - 项目类别:
Research Grant